Finance

Lists
Why is ONCO up २.४०%?
Dive Deeper
ONCO:STO
Oncopeptides AB
SEK १.७९
+२.४०%
(+०.०४२) 1D
अक्टोबर १६, ०९:४८:०५ GMT+२  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO...
Open
SEK १.७६
High
SEK १.७९
Low
SEK १.७४
Mkt. cap
६८.३४ करोड
Avg. vol.
७३.६३ लाख
Volume
५.५८ लाख
52-wk high
SEK ५.७९
52-wk low
SEK १.२५
EPS
-SEK ०.७७
Shares outstanding
३८.१४ करोड
No. of employees
६९
Open
SEK १.७६
High
SEK १.७९
Low
SEK १.७४
Mkt. cap
६८.३४ करोड
Avg. vol.
७३.६३ लाख
Volume
५.५८ लाख
52-wk high
SEK ५.७९
52-wk low
SEK १.२५
EPS
-SEK ०.७७
Shares outstanding
३८.१४ करोड
No. of employees
६९
News stories
From web sources and news partners
About Oncopeptides AB
CEO-
Employees६९
Founded२०००
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.०२ करोड
१.८६ करोड
२.५४ करोड
३.११ करोड
Cost of goods sold
२.८८ लाख
१८.५३ लाख
३.२० लाख
९.६६ लाख
Cost of revenue
२.८८ लाख
१८.५३ लाख
३.२० लाख
९.६६ लाख
Research and development expenses
१.७३ करोड
३.५९ करोड
२.१५ करोड
२.३५ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५.०९ करोड
४.३२ करोड
४.४३ करोड
५.७६ करोड
Operating expense
६.७० करोड
७.९२ करोड
६.२६ करोड
७.८८ करोड
Total operating expenses
६.७३ करोड
८.११ करोड
६.२९ करोड
७.९८ करोड
Operating income
-४.७१ करोड
-६.२५ करोड
-३.७५ करोड
-४.८७ करोड
Other non operating income
-१.०० हजार
-१.२३ करोड
१.०० हजार
-
EBT including unusual items
-६.०८ करोड
-६.४० करोड
-३.२१ करोड
-५.४६ करोड
EBT excluding unusual items
-६.०८ करोड
-६.३३ करोड
-३.२१ करोड
-५.४६ करोड
Income tax expense
१.३९ लाख
११.८२ लाख
१.२३ लाख
१.०८ लाख
Effective tax rate
-०.२३%
-१.८५%
-०.३८%
-०.२०%
Other operating expenses
-१२.२५ लाख
१.३९ लाख
-३१.७२ लाख
-२२.८९ लाख
Net income
-६.०९ करोड
-६.५२ करोड
-३.२२ करोड
-५.४७ करोड
Net profit margin
-३०१.२५%
-३५१.०२%
-१२६.७९%
-१७५.९३%
Earnings per share
-
-
-
-
Interest and investment income
-
८५.५२ लाख
५४.६८ लाख
-
Interest expense
-१.३७ करोड
-
-
-५९.३६ लाख
Net interest expenses
-१.३७ करोड
८५.५२ लाख
५४.६८ लाख
-५९.३६ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-४.६४ करोड
-६.१९ करोड
-३.७० करोड
-४.८१ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू